Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease
Clinical trial NCT01538329 · COMPLETED
Trial details
- NCT number
- NCT01538329
- Sponsor
- University Hospital, Toulouse
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-04
- Primary completion
- 2018-02-20
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.